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We have previously shown that AMP-activated protein kinase (AMPK) can induce the resumption of meiosis in mouse oocytes maintained in
meiotic arrest in vitro. The present study was carried out to determine whether AMPK activation is involved in hormone-induced maturation.
Follicle-stimulating hormone (FSH) and the EGF-like peptide, amphiregulin (AR), are potent inducers of maturation in cumulus cell-enclosed
oocytes (CEO). Within 3 h of FSH treatment, phospho-acetyl CoA carboxylase (ACC) levels were increased in germinal vesicle (GV)-stage
oocytes when compared to non-stimulated controls and remained elevated throughout 9 h of culture, indicating AMPK activation. A similar
response to AR was observed after 6 h of culture. Using anti-PT172 antibody (binds only to activated AMPK), Western analysis demonstrated
active AMPK in both FSH- or AR-treated GV-stage oocytes within 6 h. The AMPK inhibitors, compound C and adenine 9-beta-D-
arabinofuranoside (araA), blocked FSH- or AR-induced meiotic resumption and ACC phosphorylation, further supporting a causal role for AMPK
in hormone-induced meiotic resumption. Immunocytochemistry using anti-PT172-AMPK antibody showed an increased diffuse cytoplasmic
staining and more intense punctate staining in the germinal vesicles of oocytes following treatment with the AMPK activator 5-aminoimidazole-4-
carboxamide-1-beta-D-ribofuranoside (AICAR) or with FSH or AR, and this staining was eliminated by compound C or a blocking peptide for the
anti-PT172 antibody. Staining of oocytes from hCG-stimulated mice with the anti-PT172 antibody also showed pronounced label in the germinal
vesicles within 1–2 h. Furthermore, in oocytes from all groups, active AMPK was always observed in association with the condensed
chromosomes of maturing oocytes. Taken together, these results support a role for AMPK in FSH and AR-induced maturation in vitro and hCG-
induced maturation in vivo.
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In mammals, the preovulatory gonadotropin surge stimu-
lates meiotic resumption in fully grown meiotically competent
oocytes in vivo. When released from their follicles prior to the
gonadotropin surge and cultured under optimal conditions,
these oocytes spontaneously resume maturation without
hormone stimulation, suggesting an inhibitory environment
provided by the follicular somatic compartment. Several
candidate molecules produced by cumulus or granulosa cells
have been proposed to play this inhibitory role. The purine⁎ Corresponding author.
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doi:10.1016/j.ydbio.2007.09.043metabolite, hypoxanthine (HX), is present in the follicular fluid
at a concentration sufficient to maintain oocyte meiotic arrest
in vitro (Eppig et al., 1985). Another putative factor, termed
oocyte meiosis inhibitor (OMI), may also contribute to oocyte
meiotic arrest (Tsafriri and Pomerantz, 1986), though the
compound has not been biochemically characterized. More-
over, oocyte cyclic adenosine monophosphate is a critical
negative regulator of meiotic resumption (Conti et al., 2002;
Eppig et al., 2004). Agents that increase cAMP levels, cAMP
analogs, or factors that prevent degradation of cAMP
reversibly maintain oocyte meiotic arrest in vitro. Recent
evidence suggests that the oocyte is the principal site of cAMP
production that operates under the control of the somatic
compartment (Mehlmann et al., 2004; Hinckley et al., 2005;
Ledent et al., 2005).
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oocytes (CEO) under meiosis-arresting conditions and enhances
the preimplantation developmental competence of oocytes
matured in vitro (De La Fuente et al., 1999; Downs et al.,
1988). When oocyte–cumulus cell complexes are stimulated
with FSH, cumulus cells generate a gap junction-transmitted
positive signal that acts on oocytes to induce meiotic resumption
(Downs, 2001). It has also been reported that within∼0.5–2 h of
FSH treatment, the cumulus cells are stimulated to produce a
meiosis-inducing paracrine signal(s) that acts on the oocyte to
induce meiotic maturation (Byskov et al., 1997), although the
biochemical character of the signal(s) is unclear at present.
In vivo, the physiological stimulus for oocyte meiotic re-
sumption is the luteininizing hormone surge (Stapleton et al.,
1996). Distribution of the LH receptor, a G-protein coupled
receptor, is restricted to the mural granulosa cells (Peng et al.,
1991). The interaction of LH and its receptor leads to factors
released by mural granulosa cells, functioning in an autocrine
and paracrine manner to transduce the LH effects within follicle.
It has been demonstrated that in rodents members of the
epidermal growth factor (EGF) family of ligands play a critical
role in mediating LH-induced oocyte maturation (Ashkenazi
et al., 2005; Park et al., 2004). LH stimulation induces the
transient and sequential expression of the EGF family members
amphiregulin (AR), epiregulin and beta-cellulin (Park et al.,
2004). Oocytes meiotically arrested in vitro can be induced to
resume meiosis by treatment with EGF-like peptides in a
cumulus cell-dependent manner (Ashkenazi et al., 2005; Downs
and Chen, 2007; Park et al., 2004). Mice lacking AR showed
delayed hCG-induced maturation and reduced cumulus expan-
sion (Hsieh et al., 2007), indicating the physiological role of AR
in regulation of meiotic induction.
By regulating the degradation of cAMP, phosphodiesterase
(PDE) plays an essential role in oocyte meiotic resumption. In
rodents, oocyte cAMP hydrolysis is thought to be primarily
accomplished by PDE3A (Richard et al., 2001; Shitsukawa
et al., 2001). Oocytes lacking PDE3A contained increased
cAMP levels and failed to undergo spontaneous maturation in
vitro (Masciarelli et al., 2004). During oocyte maturation in vitro
or in vivo, an increase of PDE activity is observed (Han et al.,
2006; Richard et al., 2001; Tsafriri et al., 1996) and mediates a
decrease in oocyte cAMP that precedes meiotic resumption.
The activity of AMP-activated protein kinase (AMPK), a
cellular energy sensor, is sensitively regulated by AMP, a
byproduct of cAMP degradation. This protein Ser/Thr kinase,
comprised of a catalytic α subunit and regulatory β and γ
subunits, was initially discovered as an inhibitor of acetyl CoA
carboxylase and 3-hydroxy-3-methyglutaryl-CoA reductase
(Carling et al., 1987). An upstream kinase (AMPKK) activates
AMPK through specific phosphorylation on the threonine-172
(Thr172) residue of the α subunit (Hawley et al., 1996). In a
previous study, we have shown that activation of AMPK
provides a positive stimulus for mouse oocyte meiotic
resumption in vitro (Chen et al., 2006; Downs et al., 2002).
Although evidence indicates that an increase in oocyte AMPK
activity can trigger GVB, the physiological significance of this
relationship is not known.In this study, we show by Western analysis and immuno-
fluorescent staining that AMPK activity is increased in FSH- or
AR-stimulated oocytes before GVB and that hormone-induced
maturation is blocked by inhibitors of AMPK activation.
AMPK is also activated within GV-stage oocytes of hCG-
treated mice. These results provide compelling evidence for
AMPK mediation of hormone-stimulated GVB in mouse
oocytes.
Materials and methods
Oocyte isolation and culture conditions
C57BL/6JxSJL/J Fl mice, 19–23 days old, were used for all experiments.
Mice were primed with 5 IU equine chorionic gonadotropin and killed 48 h later
by cervical dislocation. Ovaries were removed and placed in the culture
medium, and cumulus cell-enclosed oocytes (CEO) were obtained by
puncturing large antral follicles with sterile needles. Oocytes were cultured in
Eagle's minimum essential medium with Earle's salts (GIBCO), supplemented
with 0.23 mM pyruvate, penicillin, streptomycin sulfate and 3 mg/ml
crystallized lyophilized bovine serum albumin (ICN ImmunoBiologicals,
Lisle, IL) and buffered with 26 mM bicarbonate. Tubes were gassed with a
humidified mixture of 5% CO2, 5% O2 and 90% N2 and placed in a water bath at
37 °C for the duration of culture.
Western analysis
After different treatments, oocytes were denuded by repeated pipetting
through mouth-operated small bore pipettes in cold culture medium and washed
in phosphate-buffered saline (PBS, pH 7.4)/PVP (3 mg/ml) plus protease
inhibitors (Protease Inhibitors Cocktail Tablets, 1 mM Na orthovanadate, 2 μg/
ml pepstatin, 50 mM beta-Glycerophospate) and then added to an equal volume
of 2× Laemmli's buffer containing 20% beta-mercaptoethanol. After heating at
95 °C for 5 min, samples were stored frozen at −80 °C until used for Western
blotting. To detect phospho-ACC levels, proteins were electrophoresed on a 3–
8% Tris-Acetate mini Gel (Invitrogen) for 1 h at 150 V and then transferred to
nitrocellulose at 100 V for 1 h. For active AMPK (PT172) blots (Figs. 1B, C),
samples were electrophoresed on a 4–12% Bis–Tris SDS mini Gel (Invitrogen)
for 50 min at 100 Vand then in a semi-dry system transferred to nitrocellulose at
250 mA for 2 h at 4 °C. After blocking with 5% nonfat milk for 2 h at room
temperature, blots were then incubated with primary antibodies (anti-PT172 or
anti-phospho-ACC, 1:250) overnight at 4 °C, washed in Tris-buffered saline
(TBS pH 7.4) and incubated with HRP-conjugated goat-anti-rabbit IgG (1:1000,
in 5% nonfat milk) for 1 h at room temperature. After washing in TBS, detection
was performed with Supersignal Western Dura Chemiluminescent Substrate
(Pierce) and exposed to film. Blots were stripped and reprobed with ACC
antiserum (1:2000) as a loading control.
Immunofluorescent staining
After different treatments, CEO were denuded and fixed with 4%
paraformaldehyde for 1 h at 4 °C and then permeabilized with 0.1% Triton in
blocking buffer (0.05% saponin in PBS, pH 7.4, plus 10% sheep serum) for
30 min. Oocytes were then washed free of Triton and continuously blocked for
another 90 min at room temperature. Oocytes were incubated with primary
antibodies (1:100) overnight at 4 °C and then washed in wash buffer (PBS
containing 1 mg/ml BSA and 0.05% saponin) and incubated with FITC-
conjugated sheep-anti-rabbit antibody (1:1000) at room temperature for 1 h.
After washing, propidium iodine (PI, 20 μg/ml) was applied to counterstain the
chromosomes. Images were observed with a confocal microscope.
Confocal microscopy
Oocytes were viewed on a laser scanning confocal microscope (Carl Zeiss
Co.) with a 40× objective. During imaging all settings were kept constant, i.e.
Fig. 1. AMPK activation in FSH- or AR-treated GV-stage oocytes. (A) Western
analysis of phospho-ACC in FSH-stimulated oocytes. CEO were denuded and
extracted after culture with or without FSH in dbcAMP-supplemented medium
for the indicated times. All oocytes were at the GV-stage, except a group of
GVB-stage oocytes were collected after 9 h FSH treatment. Western analysis of
PT172-AMPK in GV-stage oocytes after 6 h culture in the absence (Con) or
presence of 0.1 μl/ml FSH (B) or 50 ng/ml AR (C) in dbcAMP-containing
medium.
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Digitally recorded images were exported by LSM Examiner (Carl Zeiss Co.).
Chemicals
Saponin, propidium iodide, araA, dbcAMP, sheep serum, and FITC-labeled
sheep-anti-rabbit antibody were purchased from Sigma Chemical Co. (St. Louis,
MO). Compound C and AICAR were supplied by Toronto Research Chemicals,
Inc. (North York, Ontario). Anti-pACC antibody was purchased from Upstate
Biotechnology Inc. (Lake Placid, NY), anti-ACC antibodies were provided by
Dr. Grahame Hardie, anti-PT172 antibody was from Cell Signaling Technology
(Beverly, MA), and anti-PT172-specific blocking peptide came from Santa Cruz
Biotech. Inc. (Santa Cruz, CA). HRP-conjugated goat-anti-rabbit antibody and
Supersignal western dura chemiluminescent substrate were obtained from Pierce
(Rockford, IL) and vectashield mounting medium fromVector Laboratories, Inc.
(Burlingame, CA). Highly purified ovine FSH was obtained from the National
Hormone and peptide Program (NHPP), NIDDK, and Dr. A.F. Parlow.
Statistical analysis
Oocyte maturation experiments were repeated at least 3 times with at least
30 oocytes per group per experiment. Data are reported as mean percentage
GVB±SEM. Following arcsin transformation, maturation frequencies were
analyzed statistically by ANOVA followed by Duncan's multiple range test. For
all statistical analyses, a P value less than 0.05 was considered significant.Results
AMPK activity is increased in FSH-treated oocytes before GVB
dbcAMP-arrested oocytes treated with FSH initiate
meiosis between 4 and 6 h of culture and about 60% are
induced to resume maturation after 10 h (Downs and Chen,
2007). If AMPK is involved in FSH-induced maturation, it
should be activated before meiotic resumption. Acetyl CoA
carboxylase (ACC), a key enzyme involved in fatty acid
metabolism, is an important substrate of active AMPK (Davies
et al., 1992). To assess AMPK activity in FSH-treated GV-stage oocytes, a time course of phospho-ACC levels was
determined by Western analysis. CEO were cultured in
300 μM dbcAMP with or without FSH for 3, 6, or 9 h.
After culture, cumulus cells were removed and GV-stage
denuded oocytes from all culture groups or GVB-stage oocytes
from the 9 h treatment group were collected and analyzed by
Western analysis. At all time points, GV-stage oocytes treated
with FSH contained increased phospho-ACC levels compared
to the control groups (Fig. 1A), indicating that FSH stimulated
AMPK activation in the oocyte before meiotic resumption.
Interestingly, the amount of phospho-ACC decreased to the
basal level in oocytes that resumed meiosis after 9 h of FSH
stimulation.
To confirm AMPK activation and directly detect active
AMPK, Western analysis using anti-PT172 antibody was
performed. Cellular extracts were collected from GV-stage
oocytes cultured for 6 h with or without FSH in dbcAMP-
containing medium. Consistent with phospho-ACC levels,
PT172-AMPK levels were increased in FSH-stimulated GV-
stage oocytes, indicating that FSH treatment activates intra-
oocyte AMPK before oocyte maturation (Fig. 1B).
AMPK inhibitors block AMPK activation and FSH-induced
maturation
Compound C, a small molecule AMPK inhibitor (Zhou
et al., 2001), blocks AICAR-induced maturation by decreasing
AMPK activity in oocytes (Chen et al., 2006). To test whether
AMPK activation mediates FSH-induced maturation, CEO
were preincubated increasing concentrations of compound C for
0.5 h in 300 μM dbcAMP before addition of 0.1 μg/ml FSH.
After 17–18 h of culture, GVB percentage was assessed. FSH
increased the maturation percentage from 10% to 70%, and this
stimulation was eliminated in a dose-dependent manner by
compound C (Fig. 2A).
araA is the precursor of araATP, which is a competitive
inhibitor of AMPK (Henin et al., 1996), and its effects on FSH-
induced maturation were also determined. CEO were main-
tained in meiotic arrest with 300 μM dbcAMP and pretreated
with increasing concentrations of araA for 0.5 h before addition
of 0.1 μg/ml FSH. Maturation percentages were determined
after 17–18 h of culture. araA dose-dependently blocked
FSH-induced maturation, with a complete suppression at 1 mM
(Fig. 2B). These data further support the idea that AMPK
activation mediates FSH-induced maturation.
To assess the effect of compound C or araA on AMPK
activity in these oocytes, phospho-ACC levels were determined
in GV-stage oocytes by Western analysis. CEO were cultured in
300 μM dbcAMP and pretreated with 5 μM compound C or
1 mM araA for 0.5 h before addition of FSH. After 6 h of
culture, cumulus cells were removed and denuded GV-stage
oocytes were processed for Western analysis. Fig. 2C shows
that FSH treatment increased phospho-ACC levels compared to
oocytes cultured in dbcAMP alone, and exposure of FSH-
treated oocytes to either compound C or araA eliminated the
increase in ACC phosphorylation, indicating suppression of
AMPK activity within oocytes.
Fig. 2. Effects of compound C and araA on FSH-induced maturation and ACC
phosphorylation. CEO were precultured for 0.5 h with increasing doses of
compound C (A) or araA (B) in 300 μM dbcAMP. FSH (0.1 μg/ml) was then
added and cultures were continued for 17–18 h before assessment of GVB
percentage. Groups with no common letters are significantly different. (C)
Western analysis of phospho-ACC in compound C or araA-treated GV-stage
oocytes. CEO were preincubated 0.5 h with 5 μM compound C or 1 mM araA in
300 μM dbcAMP before addition of FSH. After 6 h of culture, GV-stage oocytes
were prepared for Western analysis.
Fig. 3. Effects of compound C and araA on AR-induced maturation and ACC
phosphorylation. CEO were pretreated with increasing concentrations of
compound C (A) or araA (B) in 300 μM dbcAMP for 0.5 h. AR (50 ng/ml)
was then added and cultures were continued for 17–18 h before assessment of
GVB. Groups with no common letters are significantly different. (C) Western
analysis of phospho-ACC in compound C or araA-treated oocytes. CEO were
preincubated 0.5 h with 5 μM compound C or 2 mM araA in 300 μM dbcAMP
before addition of AR. CEO were denuded after 6 h of culture and GV-stage
oocytes were collected and processed for Western analysis.
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Amphiregulin (AR), an EGF-like peptide, mediates LH-
stimulated maturation in vivo (Hsieh et al., 2007) and induces
CEO meiotic resumption in vitro (Downs and Chen, 2007; Park
et al., 2004). To test whether AMPK activation is involved in
AR-induced maturation, after 6 h treatment in the absence or
presence of AR, CEO were denuded and extracts from 500 GV-stage oocytes were subjected to Western analysis. As shown in
Fig. 1C, active AMPK and phospho-ACC levels were elevated
in AR-treated oocytes before meiotic maturation.
The AMPK inhibitors, compound C and araA, were tested on
AR-induced maturation to assess the involvement of AMPK.
CEO were pretreated with increasing concentrations of
compound C or araA in dbcAMP-containing medium for
0.5 h before addition of 50 ng/ml AR, and cultures were
continued for 17–18 h before assessment of GVB. AR increased
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dose-dependently blocked by compound C (Fig. 3A) or araA
(Fig. 3B). Western analysis showed that the AR-stimulated
phosphorylation of ACC was suppressed by compound C or
araA (Fig. 3C), demonstrating inactivation of AMPK.
Immunofluorescent localization of active AMPK
(PT172-AMPK)
AICAR stimulation
Immunofluorescent staining using anti-PT172 antiserum was
performed to directly observe active AMPK in the oocytesFig. 4. Localization of active AMPK in AICAR-stimulated CEO. After 6 h of cultur
PT172 AMPK antiserum followed by FITC-labeled sheep anti-rabbit antiserum. (A)
stage; (D) AICAR, GV-stage; primary antibody was neutralized with a specific bloc
with 5 μM compound C in 300 μM dbcAMP before the addition of 1 mM AICAR. O
bar represents 50 μm.following treatment with the AMPK activator, AICAR. After
6 h of culture in medium containing dbcAMP with or without
1 mM AICAR, oocytes were denuded, fixed with 4%
paraformaldehyde and stained for immunofluorescence using
anti-PT172 antiserum. Counterstaining with propidium iodide
(PI) enabled an assessment of AMPK localization in relation to
the germinal vesicle in immature oocytes or condensed
chromosomes following meiotic resumption. Control groups
for nonspecific staining were carried out in which either primary
antibody was omitted or a blocking peptide representing the
phosphorylated peptide recognition site was added to neutralize
the primary antibody. In the control group, in which primarye, cumulus cells were removed and DO were fixed and stained with rabbit anti-
dbcAMP alone (control), GV-stage; (B) AICAR, GV-stage; (C) AICAR, GVB-
king peptide; (E) AICAR plus compound C, GV-stage; CEO were preincubated
ocytes were stained with propidium iodide (PI) for detection of chromatin. Scale
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distributed throughout the oocyte (data not shown). Fluores-
cence was never seen in the nucleolus in any of the groups.
Oocytes meiotically arrested in dbcAMP-supplemented med-
ium contained a diffuse fluorescence throughout the cell, which
was above the background (Fig. 4A). AICAR stimulation
resulted in a stronger diffuse signal in the cytoplasm, but most
notable was an intense punctate labeling in the germinal vesicle
(Fig. 4B). In all GVB-stage oocytes, even those spontaneously
maturing in dbcAMP alone, a punctate staining pattern was
observed associated with the condensed chromosomes (Fig.
4C). Pretreatment of oocytes with compound C (Fig. 4D) or
pretreatment of antibody with a blocking peptide containing the
specific peptide sequence recognized by the antibody (Fig. 4E)
eliminated both the increased cytoplasmic staining as well as the
punctate nuclear staining. When quantified, 75% of AICAR-
treated GV-stage oocytes exhibited nuclear staining, compared
to 11% of controls, and compound C completely prevented the
AICAR-stimulated response (Fig. 5).
FSH stimulation
To test if FSH-treated oocytes exhibited a similar staining
pattern, immunocytochemistry was performed on dbcAMP-
arrested CEO stimulated with FSH for 6 h. Similar to AICAR-
stimulated CEO, GV-stage oocytes treated with FSH exhibited
increased diffuse staining in the cytoplasm and intense punctate
fluorescence in the nucleus (Fig. 6B) compared to a faint diffuse
staining pattern in untreated controls (Fig. 6A). When oocytes
resumed meiosis, active AMPK was again consistently
observed in association with the condensed chromosomes.
Compound C, at a concentration that eliminated FSH-induced
maturation, also prevented the punctate nuclear staining and
reduced the diffuse cytoplasmic staining (Figs. 6D, 7).
Amphiregulin stimulation
Experiments were next performed to determine the active
AMPK staining pattern in AR-treated oocytes. dbcAMP-
arrested CEO treated 6 h with AR exhibited the same patternFig. 5. Effect of compound C on the percentage of GV-stage oocytes that
contained nuclear PT172 staining after 6 h of culture in 1 mM AICAR.of staining, with an increase in diffuse cytoplasmic staining
and pronounced punctate staining in the germinal vesicle of
immature oocytes (Fig. 8B) and around the condensed
chromosomes of oocytes that had resumed maturation (Fig.
8C). Compound C again prevented this increased staining
(Fig. 8D).
When a dose response experiment was carried out with AR
using concentrations of 2.5, 10, and 50 ng/ml, a dose-dependent
stimulation of meiotic resumption in dbcAMP-arrested oocytes
was observed that was paralleled by corresponding increases in
the frequency of nuclear staining in GV-stage oocytes using
anti-PT172 antibody (Fig. 9A). Thus, as the maturation-
inducing potency of AR was increased, so was its ability to
stimulate AMPK activation within the GVof immature oocytes.
Compound C abolished the increased nuclear staining brought
about by 50 ng/ml AR (Fig. 9B).
hCG stimulation in vivo
To determine if AMPK activation within the oocytes occurs
prior to meiotic resumption in vivo, eCG-primed mice were
treated with 5 IU hCG and oocyte–cumulus cell complexes
were isolated at 1, 2 and 3.5 h post-hCG and processed for
immunofluorescence using anti-PT172 antibody. A separate set
of primed mice was injected with the PBS vehicle as controls.
As shown in Fig. 10, very little label was detected in the 0 h
group, but as early as 1 h after hCG injection a slight increase in
staining intensity was evident in the germinal vesicle that
became very pronounced after 2 h. In two experiments, 41 out
of a total of 74 oocytes (55.4%) isolated 2 h post-hCG displayed
this increased nuclear staining. As with oocytes stimulated in
vitro, blocking peptide eliminated the increase in nuclear
fluorescence (data not shown), confirming the specificity for
active AMPK in vivo. Such staining was not observed in
oocytes from vehicle-treated mice at any time point. Nearly all
of the oocytes (90%) isolated 3.5 h post-hCG had undergone
GVB and, of these, 100% showed intense phospho-PT172
staining that colocalized with the condensed chromosomes (Fig.
10). Although an increase in diffuse cytoplasmic fluorescence
was apparent in oocytes that had resumed maturation, this
increase was more subtle in immature oocytes from hCG-
stimulated animals. Interestingly, a common finding in oocytes
from hCG-treated mice was foci of intense staining in the
cytoplasm and sometimes in the germinal vesicle that were
usually larger than the aggregations of label in oocytes receiving
an inducing signal in vitro.
Discussion
In this study, we have demonstrated the participation of
AMPK in hormone-induced maturation of mouse CEO in vitro.
FSH triggered AMPK activation in oocytes before meiotic
resumption, and the AMPK inhibitors, compound C and araA,
blocked both FSH-induced maturation and the FSH-stimulated
increase in AMPK activity in GV-stage oocytes. Identical
results were observed in AR-stimulated oocytes. By immuno-
fluorescence microscopy using anti-PT172 antibody, increased
diffuse cytoplasmic staining and punctate staining in the
Fig. 7. Effect of compound C on the percentage of GV-stage oocytes that
contained nuclear PT172-AMPK staining after 6 h of culture in FSH.
Fig. 6. Localization of active AMPK in FSH-stimulated CEO. After 6 h of culture, cumulus cells were removed and DO were fixed and stained with rabbit anti-PT172
AMPK antiserum followed by FITC-labeled sheep anti-rabbit antiserum. (A) dbcAMP alone (control), GV-stage; (B) FSH (0.1 μg/ml), GV-stage; (C) FSH (0.1 μg/ml),
GVB-stage; (D) FSH (0.5 μg/ml) plus compound C, GV-stage; CEO were preincubated with 5 μM compound C in 300 μM dbcAMP before the addition of FSH.
Oocytes were stained with propidium iodide (PI) for detection of chromatin. Scale bar represents 50 μm.
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or AR, similar to the staining pattern in AICAR-stimulated
oocytes. With each stimulatory protocol, the increase in active
AMPK staining was eliminated by compound C. AMPK was
also shown to be activated prior to meiotic resumption in
oocytes from hCG-stimulated mice. These results demonstrate
the essential involvement of AMPK in hormone-induced
maturation.
FSH is an effective inducer of meiotic resumption in arrested
mouse CEO in vitro. FSH binding to its receptor on the cumulus
cells activates a cAMP-regulated pathway (Tayar, 1996) and
generates a positive stimulus to induce maturation in a gap
junction-dependent manner (Downs, 2001; Downs et al., 1988).
The nature of this positive stimulus and the means by which it
brings about GVB remain active areas of research. We show that
FSH stimulation for 3 h is sufficient to increase ACC
phosphorylation in GV-stage mouse oocytes, indicating
AMPK activation. In addition, immunoblotting and
Fig. 8. Localization of active AMPK in AR-stimulated CEO. After 6 h of culture, cumulus cells were removed and DO were fixed and stained with rabbit anti-PT172
AMPK antiserum followed by FITC-labeled sheep anti-rabbit antiserum. (A) dbcAMP alone (control), GV-stage; (B) AR, GV-stage; (C) AR, GVB-stage; (D) AR plus
compound C, GV-stage; CEO were preincubated with 5 μM compound C in 300 μM dbcAMP before the addition of AR. Oocytes were stained with propidium iodide
(PI) for detection of chromatin. Scale bar represents 50 μm.
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directly showed an increase of active AMPK in FSH-treated
GV-stage oocytes. These observations are consistent with
AMPK involvement in FSH-induced meiotic resumption since
the kinase is activated prior to meiotic resumption. Support for
this idea was provided by the use of the AMPK inhibitors,
compound C (Zhou et al., 2001) and araA (precursor of araATP,
(Henin et al., 1996)), which blocked both hormone-induced
maturation and AMPK activation.
In a normal reproductive cycle, it is the LH surge that
regulates oocyte maturation in vivo. It has been shown that
EGF-like peptides, such as amphiregulin (AR), epiregulin and
beta-cellulin, mediate LH-induced effects on oocyte meiotic
maturation in rodents (Ashkenazi et al., 2005; Hsieh et al.,
2007; Park et al., 2004). A model system has been proposed in
which secretion of EGF-like peptides by the mural granulosa
cells in response to gonadotropin stimulation functions in anautocrine and paracrine manner to transduce the hormone
effects in the follicle (Park et al., 2004). In cultured CEO, FSH
induces AR mRNA expression within 0.5 h by a prostaglandin
synthase 2 and progesterone receptor-dependent mechanism
(Shimada et al., 2006). In addition, a recent study showed that
AR mediates FSH-induced maturation in mouse oocytes in vitro
(Downs and Chen, 2007). Therefore, it was important to test
whether AMPK is involved in oocyte maturation mediated by
EGF-like peptides. Indeed, Western analysis indicated that AR
induces AMPK activation in mouse oocytes before GVB, and
this was confirmed by immunocytochemistry. Moreover, as in
FSH-treated CEO, AR-induced oocyte maturation and AMPK
activation were blocked by AMPK inhibitors, further support-
ing the involvement of AMPK in AR-induced maturation.
By immunofluorescent staining, we showed that a consider-
able portion of active AMPK α subunit accumulated in the
germinal vesicle after AICAR, FSH or AR stimulation in vitro
Fig. 9. Effects of AR and compound C on nuclear PT172-AMPK staining. (A)
Effect of AR dose on oocyte maturation and nuclear staining. CEO were
cultured 6 h in medium containing 300 μM dbcAMP plus increasing dose of
AR and the frequencies of both GVB and nuclear staining in GV-stage oocytes
were determined. (B) Inhibitory effect of compound C on the percentage of GV-
stage oocytes that contained nuclear PT172-AMPK staining after 6 h of culture
in AR.
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specificity of this staining stems from its elimination by
treatment of oocytes with compound C or treatment of antibody
with a specific blocking peptide. In Drosophila melanogaster,
the AMPK homologue, DmAMPK, has also been shown to be
associated with the nucleus when it was activated by
oligomycin (Pan and Hardie, 2002). Moreover, in yeast, the
AMPK homologue, SNF1, translocalizes from cytoplasm to the
nucleus in response to alkaline pH but not sodium ion stress
(Hong and Carlson, 2007). It is tempting to speculate that active
AMPK within the germinal vesicle is important for its meiosis-
inducing action. However, it should be noted that an increased
diffuse cytoplasmic staining was also observed in stimulated
CEO, though it was of lesser intensity.
In mammals, the AMPK catalytic subunit contains two
isoforms, α1 and α2, which are encoded by different genes. In
somatic cells, α1-AMPK is only present in the cytoplasm,whereas α2 is mainly localized in the nucleus (Salt et al., 1998;
Stapleton et al., 1996; Turnley et al., 1999). A recent study
showed that in a mouse myoblast cell line, α2 and α1 isoforms
are both localized in the cytoplasm, while activation of AMPK
results in α2, but not α1, translocation into the nucleus (Suzuki
et al., 2007). Interestingly, we have observed increased α1
AMPK accumulation in or around the germinal vesicle of
AICAR-stimulated oocytes (unpublished data), suggesting a
movement of this subunit from the cytoplasm into the GV prior
to meiotic resumption. Thus, different active AMPK isoform
dynamics may be manifest in mouse oocytes when compared to
somatic cells, but clarification awaits further study. Immuno-
fluorescent staining of oocytes from hCG-stimulated animals
also revealed that AMPK was activated prior to GVB in vivo.
An increase in fluorescence was observed 1 h after hCG
injection that became significantly more intense by 2 h post-
hCG. Moreover, as was observed in oocytes stimulated in vitro
by AICAR, FSH or AR, active AMPK was always observed in
association with the condensed chromosomes of maturing
oocytes. Taken together, our data support a physiological role
for AMPK in hormone-induced maturation both in vitro and in
vivo. However, an interesting difference in staining pattern was
observed in that oocytes in vitro tended to have smaller,
punctate staining, while those maturing in vivo had fewer, but
larger, concretions of fluorescence. The significance of these
differences is not known and they provide a challenge for future
experimentation.
The observation that active AMPK accumulated around the
periphery of condensed chromosomes in all maturing oocytes
suggests that AMPK participates in subsequent events leading
to the completion of meiosis I, such as the segregation of
chromosomes. Indeed, we have reported increased frequencies
of metaphase II oocytes following in vitro culture in the
presence of AICAR (Downs and Chen, 2006). A study in
Saccharomyces cerevisiae has shown that the AMPK homo-
logue, SNF1, is required for both early (DNA replication and
meiotic recombination) and late (meiotic chromosome segrega-
tion and spore formation) stages of meiosis through different
mechanisms (Honigberg and Lee, 1998). It will be interesting to
determine the pattern of AMPK activation throughout matura-
tion and fertilization in the mouse and its involvement in these
later developmental stages.
Data presented herein and in previous studies have
demonstrated a meiosis-inducing action of AMPK in mouse
oocytes. The present study is important because it implicates
AMPK in hormone-induced oocyte maturation in the mouse,
thereby verifying a physiological role in meiotic regulation.
Curiously, in oocytes from two other species, cow and pig,
AMPK has the opposite action on oocyte maturation (Bilodeau-
Goeseels et al., 2007; Mayes et al., 2007; Tosca et al., 2007). In
a recent study, Mayes et al. (2007) showed that activation of
AMPK transiently suppressed the spontaneous maturation of
pig oocytes and that this effect was mediated by the cumulus
cells. A similar cumulus cell-dependent inhibitory effect was
reported by Tosca et al. (2007) when bovine oocytes were
treated with the AMPK activator metformin. Bilodeau-Goeseels
et al. (2007) also reported suppression of bovine maturation
Fig. 10. Localization of active AMPK in oocytes from hCG-stimulated mice. eCG-primed mice were injected with 5 IU hCG and 0, 1, 2 or 3.5 h later oocytes were
isolated, fixed and stained with rabbit anti-PT172 AMPK antiserum followed by FITC-labeled sheep anti-rabbit antiserum. Oocytes were stained with propidium
iodide (PI) for detection of chromatin. Note that two cumulus cell nuclei stain intensely with propidium iodide on the bottom portion of the micrograph of the 1 h
group. Scale bar represents 50 μm.
56 J. Chen, S.M. Downs / Developmental Biology 313 (2008) 47–57with AICAR and metformin, but these agents were effective in
both CEO and DO. These findings are striking not only
because the response to AMPK activation is one of meiotic
suppression, but also because the site of action may vary
between germ and somatic compartments. Thus, fundamental
differences exist in meiotic regulation of mammalian oocytes
that serve to emphasize the difficulty in extrapolating
experimental findings to another species. As a further example
of this, in preliminary experiments we have been unable to
stimulate GVB in rat oocytes with AICAR or a brief heat
shock, both of which are effective meiotic inducers in mice
(Downs et al., 2002; LaRosa and Downs, 2007). It is apparent
that the mouse possesses unique physiological characteristics
associated with the control of meiotic resumption. A future
challenge will be the delineation of similarities as well as
differences between mammalian species in how oocyte ma-
turation is regulated.References
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